Clinical trials

  • PACLITAXEL for Borderline resectable pancreatic ductal adenocarcinoma|Pancreatic adenocarcinoma
  • Lebrikizumab for Atopic dermatitis|Atopic eczema
  • CRGD-ZW800-1 for Squamous cell carcinoma of the larynx and hypopharynx
  • PF-08052667 for Non-muscle invasive bladder cancer
  • INTESTIFIX for Multidrug-resistant Enterobacteriaceae colonization (intestinal carriage) | Multidrug-resistant Enterobacteriaceae infection
  • RILZABRUTINIB for Graves' disease|Graves' orbitopathy
  • Colecalciferol for Healthy volunteers
  • GSK5764227 for Gastrointestinal neoplasms|Colorectal cancer|Pancreatic adenocarcinoma
  • AG-946 PHOSPHATE for Sickle cell disease
  • Allergenic extract of grass pollen mixture: Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pratense and Poa pratensis (1:1:1:1:1), polymerised for Allergic rhinoconjunctivitis (grass pollen-induced)|Seasonal allergy|Asthma (controlled, comorbidity)
  • BUDOPRUTUG for Immune thrombocytopenia (ITP)|Primary immune thrombocytopenia
  • HUMAN IGG4 S228P MONOCLONAL ANTIBODY AGAINST FACTOR XI AND ACTIVATED FACTOR XI for Venous thromboembolism (VTE) | Thromboembolic disease